Previous 10 | Next 10 |
Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B PR Newswire Inhibrx, Inc. shareholders will receive per share consideration of $30 per share in cash, a CVR equal to $5 , plus 0.25 shares in New Inhibrx, a new publicly traded company ...
2024-01-22 09:45:09 ET Digital World Acquisition Corp. Class A Common Stock (DWAC) DWAC is trading UP for the last 5 days, and it at trading at $33.19 with volume of 4,896,844 and a one day change of $6.81 (25.80%). Digital World Acquisition Corp. Class A Common Stock has a 52-week ...
2024-01-22 08:50:51 ET Summary Positive preliminary results were achieved in early-stage studies of its protein degraders, NX-2127 and NX-5948, for the treatment of B-cell malignancies. Protein degradation platform offers several advantages over other BTK drugs, such as ability to...
2024-01-19 08:05:15 ET More on Bristol-Myers, J&J, etc. Johnson & Johnson: Is The Dividend Still Safe After The Kenvue Split-Off? Johnson & Johnson Remains A Safe Bet Amidst Talc Lawsuits And Ambrx Acquisition Bristol-Myers Squibb: Big Dividend Yield, Unl...
2024-01-14 12:50:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. International markets ...
2024-01-12 00:25:11 ET Summary Novo Nordisk is the market leader of the fast-growing obesity care industry, which is expected to grow above 20% CAGR until 2030. The company raised three times its guidance during 2023, driven by a 481% growth in Wegovy's revenues. The company i...
2024-01-11 08:42:53 ET Summary Innate Pharma is a European biotech specializing in the development of immunotherapeutics for various cancer types. Their most advanced projects focus on engaging and activating natural killer cells, with promising results in clinical trials. The...
2024-01-09 18:04:24 ET Summary Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may b...
2024-01-09 17:35:28 ET Sanofi (SNY) J.P. Morgan 42nd Annual Healthcare Conference Call January 9, 2024, 13:30 PM ET Company Participants Paul Hudson - Chief Executive Officer Jean-Baptiste de Chatillon - Executive Vice President and Chief Financial Officer Houman...
2024-01-09 14:26:52 ET More on Sanofi Sanofi: Expect A Weak 2024 Leading Up To A Strong 2025 R&D Day Sanofi: A Shift In The Story FDA evaluating reports of GLP-1 drugs and negative side effects Scribe Therapeutics expands collaboration with Sanofi...
News, Short Squeeze, Breakout and More Instantly...
Sanofi ships U.S. influenza vaccines for the 2024/25 season PR Newswire Customers will start receiving shipments from July 10 with additional shipments through October to healthcare provider offices, pharmacies and other immunizers to support fall immunization campaigns. ...
2024-07-09 06:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...